Chemicals

Rutile Projects Gain Value Amid Supply Scarcity
Manufacturing Rutile Projects Gain Value Amid Supply Scarcity

The global titanium supply chain is undergoing a profound and irreversible transformation, driven by a confluence of structural supply deficits, nascent demand recovery, and significant geopolitical realignments that are fundamentally reshaping the industry. This complex interplay is dramatically

Can Automation Save Cell and Gene Therapy?
Manufacturing Can Automation Save Cell and Gene Therapy?

The Promise and Peril of a Medical Revolution Cell and gene therapies stand at the forefront of a medical revolution, offering the potential to cure diseases once considered untreatable. Yet, this groundbreaking sector is caught in a profound paradox. While the science is delivering unprecedented

How Will Shivtek Revolutionize Indian Chemicals?
Manufacturing How Will Shivtek Revolutionize Indian Chemicals?

As India's specialty chemical sector stands at a critical juncture, balancing rapid industrial growth with an urgent need for sustainability and self-reliance, one company is stepping forward with a transformative agenda. Shivtek Spechemi Industries Ltd., the flagship of the Shiva Group of

Is Platinum Pushing Chemicals to a Tipping Point?
Manufacturing Is Platinum Pushing Chemicals to a Tipping Point?

The global chemical industry is grappling with a severe financial challenge as platinum, a metal indispensable to countless synthesis processes, experiences a price surge of historic proportions. This dramatic and volatile escalation has sent shockwaves through manufacturing sectors, forcing

Is the US Biomanufacturing Boom Sustainable?
Manufacturing Is the US Biomanufacturing Boom Sustainable?

A seismic shift is underway across the American industrial landscape, where an unprecedented surge of capital is fueling the rapid expansion of facilities designed to produce the next generation of life-saving medicines. This article analyzes the unprecedented surge in U.S. biomanufacturing

Eli Lilly Invests Billions to Boost U.S. Drug Manufacturing
Manufacturing Eli Lilly Invests Billions to Boost U.S. Drug Manufacturing

A quiet but monumental shift is reshaping the foundations of the pharmaceutical industry, driven by a convergence of unprecedented demand for new therapies and the fragile realities of a globally interconnected supply chain. Eli Lilly and Company is at the forefront of this transformation,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later